Sp329
AGA MORTON I. GROSSMAN DISTINGUISHED LECTURE: TBD
Date
May 18, 2024
Tracks
Related Products
MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
Screening for Barrett’s esophagus (BE) could lead to earlier detection and improved survival of esophageal adenocarcinoma (EAC)…
BIOMARKER RISK STRATIFICATION USING THE CAPSULE SPONGE FOR THE SURVEILLANCE OF BARRETT'S ESOPHAGUS: INTERIM RESULTS FROM THE UK REAL-WORLD IMPLEMENTATION PILOTS.
Endoscopic surveillance is recommended for Barrett’s esophagus (BE), but the effectiveness is questionable and varies according to expertise. Pan-oesophageal cell collection devices with biomarkers offer a less operator dependent alternative…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…